Torrent Pharma's Q4 net profit stands at Rs 357 crore
DSIJ Intelligence / 24 May 2016
The flagship company of Torrent Group, Torrent Pharma on May 23 has declared its Q4FY16 results, wherein the company recorded a net profit of Rs 357 crores.
The flagship company of Torrent Group, Torrent Pharma on May 23 has declared its Q4FY16 results, wherein the company recorded a net profit of Rs 357 crores. Net profit of Torrent Pharma has increased 3 folds as compared to Q4FY15. EBITDA for the period stands at Rs 484 crores, which has increased 3 times over the previous quarter. Total income from operations stands at Rs 1499 crores for the quarter, as against Rs 1154 crores for the corresponding period of the previous fiscal. Total income of the company has increased by 30 per cent.
On a YoY basis, net profit for the period stands at Rs 1722 crores, whereas for the previous fiscal, the company has reported a net profit of Rs 751 crores. EBITDA stands at Rs 2720 crores, while previously EBITDA was reported at Rs 1020 crores. Consolidated total income for the period stands at Rs 6676 crores.
"The figures for the quarter ended December 31, 2015 and March 31, 2016 are after giving effect of scheme of amalgamation while figures for the corresponding quarters are before giving effect of amalgamation,” and hence the figures of the corresponding period and previous year are not comparable with the figures of the current period.
The company has posted robust numbers in this quarter largely due to robust sales recorded in the US market.
On a CAGR basis, the company’s EBITDA and net profits for the period of 3 years has grown by 69 per cent and 61 per cent, respectively. Company’s volumes have grown by 26 per cent.
Torrent Pharmaceuticals Limited is a Indian pharmaceutical company. The company has presence in cardiovascular (CV) and central nervous system (CNS), gastro-intestinal, diabetology, anti-infective and pain management segments. The Company operates only in one business segment viz. pharmaceuticals, comprising mainly of manufacture of branded formulations.
The shares of the company on Tuesday have opened negative and are trading at Rs 1311, down by 11 per cent. The government ban on fixed dose combination (FDC) drugs has taken a toll on pharmaceuticals stocks. The BSE health care index has plunged by 2 per cent in the last 3 months.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.